secwatch.observer — SEC 8-K summary
======================================

Issuer:     Anixa Biosciences Inc (ANIX)
CIK:        0000715446
Form:       8-K
Filed at:   2022-03-11T23:59:59+00:00
Accession:  0001493152-22-006637
Event type: other
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.07, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Anixa stockholders re-elect four directors, approve exec compensation, ratify auditor at 2022 annual meeting
--------------------------------------------------------------------------------

- Re-elected directors Dr. Amit Kumar, Dr. Arnold Baskies, Emily Gottschalk, and Lewis H. Titterton, Jr. with between 8.4M and 9.2M votes for.
- Non-binding advisory vote on executive compensation approved: 6,670,331 for, 2,450,849 against, 188,009 abstain, 9,914,423 broker non-votes.
- Ratified appointment of Haskell & White LLP as auditor for FY ending Oct 31, 2022: 19,035,845 for, 193,874 against, 83,893 abstain.
- Total shares present at meeting: 19,313,612 of 30,132,319 outstanding shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/715446/000149315222006637/0001493152-22-006637-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/715446/000149315222006637/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-006637

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer